Andrew Sinclair
CIK 1762451 · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$972.55M
Companies
6
Total Filings
33
Lifetime Open-Market Net
$33.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLNO | Director | 18,022,602 | $53.01 | $955.38M | $5.50M | 11 | 2026-05-18 |
| ACET | Director | 2,133,085 | $8.05 | $17.17M | $14.00M | 10 | 2025-06-13 |
| NCNA | Director | — | $1.95 | — | $0 | 1 | 2024-08-23 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $4.05M | 7 | 2022-07-01 |
| Verona Pharma plc (VRNA) Delisted | Director | — | $106.91 | — | $0 | 1 | 2021-08-10 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | 6,969,272 | — | — | $10.23M | 3 | 2019-10-29 |
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-04 | ACET | Grant (A) | — | $0 | EDGAR |
| 2021-03-16 | ACET | Grant (A) | — | $0 | EDGAR |
| 2021-03-04 | ACET | Grant (A) | — | $0 | EDGAR |
| 2021-01-12 | SLNO | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | SLNO | Buy (P) | +3,333,330 | $5.50M | EDGAR |
| 2020-06-10 | Sierra Oncology, Inc. (SRRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-20 | SLNO | Grant (A) | — | $0 | EDGAR |
| 2020-02-03 | Sierra Oncology, Inc. (SRRA) Delisted | Conv (C) | +871,240 | $0 | EDGAR |
| 2020-01-31 | Sierra Oncology, Inc. (SRRA) Delisted | Conv (C) | +871,125 | $0 | EDGAR |
| 2019-12-03 | Sierra Oncology, Inc. (SRRA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.